These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7830238)

  • 1. Bioavailability and disposition of terodiline in man.
    Hallén B; Karlsson MO; Stromberg S; Norén B
    J Pharm Sci; 1994 Sep; 83(9):1241-6. PubMed ID: 7830238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of R(+)-terodiline given intravenously and orally to healthy volunteers.
    Hallén B; Gabrielsson J; Palmér L; Ekström B
    Pharmacol Toxicol; 1993 Sep; 73(3):153-8. PubMed ID: 8265519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of terodiline and a major metabolite in dogs with a correlation to a pharmacodynamic effect.
    Hallén B; Grälls M; Brötell H; Strömberg S
    Pharmacol Toxicol; 1990 May; 66(5):373-81. PubMed ID: 2371244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant single-dose and multiple-dose pharmacokinetics of terodiline in man, with a note on its enantiomers and major metabolites.
    Hallén B; Gabrielsson J; Nyambati S; Johansson A; Larsson E; Guilbaud O
    Pharmacol Toxicol; 1995 Mar; 76(3):171-7. PubMed ID: 7617541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics of terodiline in geriatric patients.
    Hallén B; Magnusson A; Bogentoft S; Ekelund P
    Eur J Clin Pharmacol; 1988; 34(3):291-7. PubMed ID: 3396620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and steady-state pharmacokinetics of terodiline and its main metabolites in elderly patients with urinary incontinence.
    Hallén B; Bogentoft S; Sandquist S; Strömberg S; Setterberg G; Ryd-Kjellén E
    Eur J Clin Pharmacol; 1989; 36(5):487-93. PubMed ID: 2753067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose pharmacokinetics of terodiline, including a stable isotope technique for improvement of statistical evaluations.
    Hallén B; Guilbaud O; Strömberg S; Lindeke B
    Biopharm Drug Dispos; 1988; 9(3):229-50. PubMed ID: 3395665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of terodiline in human volunteers.
    Karlén B; Andersson KE; Ekman G; Strömberg S; Ulmsten U
    Eur J Clin Pharmacol; 1982; 23(3):267-70. PubMed ID: 7173296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical instillation of terodiline--an in vivo study of drug absorption in rabbit and man.
    Ekström B; Larsson B; Andersson KE; Mattiasson A
    J Urol; 1993 Dec; 150(6):1926-31. PubMed ID: 8230539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability and noncompartmental analysis of intravenous and intramuscular Cefotan (cefotetan) in normal volunteers.
    Zimmerman J; Cohen A; Thyrum P
    J Clin Pharmacol; 1989 Feb; 29(2):151-7. PubMed ID: 2715372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, Disposition, and Biotransformation of [
    Trivedi A; Wahlstrom J; Mackowski M; Dutta S; Lee E
    Drug Metab Dispos; 2021 Aug; 49(8):619-628. PubMed ID: 34011533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man.
    Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF
    Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of terodiline. III. Opposed stereoselectivity in the benzylic and aromatic hydroxylations in rat liver microsomes.
    Lindeke B; Ericsson O; Jönsson A; Noren B; Strömberg S; Vangbo B
    Xenobiotica; 1987 Nov; 17(11):1269-78. PubMed ID: 3433799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of cotinine after oral and intravenous administration to man.
    De Schepper PJ; Van Hecken A; Daenens P; Van Rossum JM
    Eur J Clin Pharmacol; 1987; 31(5):583-8. PubMed ID: 3830243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.